Is MLH9 implicated in breast cancer?
Best insight from top research papers
MLH9 is not implicated in breast cancer based on the provided abstracts.
Answers from top 4 papers
More filters
| Papers (4) | Insight |
|---|---|
| The provided paper does not mention MLH9 or its implication in breast cancer. | |
29 Citations | The paper does not mention MLH9 or its implication in breast cancer. The paper discusses the role of hsp27, MMP-9, and Yes in breast cancer metastasis. |
11 Citations | The provided paper does not mention MLH9 or its implication in breast cancer. The paper focuses on the role of MMP-9 in increasing HER2/neu expression and altering apoptosis levels in human mammary epithelial cells. |
55 Citations | The provided paper does not mention MLH9 or its implication in breast cancer. |
Related Questions
What is the molecular mechanism of MMP9 in promoting perineural invasion in cancer?5 answersMatrix metalloproteinase 9 (MMP9) plays a crucial role in promoting perineural invasion (PNI) in cancer by affecting tumor microenvironment, invasion, metastasis, and angiogenesis. Studies have shown that MMP9 levels are elevated in tissues with combined growth of melanoma and lung carcinoma, indicating its involvement in cancer development. Furthermore, the co-expression of CXCL8 and MMP9 has been identified as a potential early detection marker for PNI, with high expression correlating with worse disease-free survival in gastric cancer patients. Additionally, targeting MMP9 has been shown to reduce penetration across the blood-brain barrier and limit micrometastasis formation in the brain, highlighting its significance in facilitating metastatic tumor cell dissemination in the brain.
Whar the are the genes involved in causing breast cancer and why ?5 answersBreast cancer is influenced by various genes, including high-penetrance genes like BRCA1, BRCA2, PTEN, TP53, CDH1, and STK11, as well as genes with moderate penetrance such as CHEK2, BRIP1, ATM, and PALB2. Mutations in these genes can lead to hereditary predisposition to breast cancer, characterized by earlier onset and familial clustering. BRCA1 and BRCA2, in particular, play crucial roles in DNA repair mechanisms, and mutations in these tumor suppressor genes can result in tumorigenesis. Synthetic lethality, such as the relationship between PARP and BRCA genes, has been explored for targeted cancer therapy, with PARP inhibitors like Olaparib showing promise in treating BRCA1/2-related breast and ovarian cancers. Understanding the functional characteristics and interactions of oncogenes and tumor suppressor genes is vital in deciphering their roles in breast cancer development.
What are the most significant genetic risk factors associated with breast cancer?5 answersThe most significant genetic risk factors associated with breast cancer include high-penetrance genes like BRCA1, BRCA2, PTEN, TP53, CDH1, and STK11, as well as moderate penetrance genes such as CHEK2, BRIP1, ATM, and PALB2. Additionally, rare high- and moderate-penetrance germline variants in genes involved in the DNA damage response (DDR) like BRCA1, BRCA2, PALB2, ATM, and TP53 contribute to breast cancer risk. Rare high-risk loci identified through haplotypes, rather than single variants, have also been linked to breast cancer risk, indicating the presence of novel risk loci. Furthermore, genome-wide studies have identified 222 genetic risk loci and 137 genes associated with breast cancer risk, with some showing subtype-specific associations. Utilizing allelic expression ratios has helped identify causal risk variants and target genes, such as STXBP4 and COX11, at the 17q22 breast cancer risk locus.
What is the Molecular mechanism of breast cancer?5 answersBreast cancer is a complex pathology characterized by the uncontrolled proliferation and growth of cells in the breast tissue. The molecular mechanisms underlying breast cancer involve genetic and environmental risk factors, as well as changes in signaling mechanisms mediated by estrogen and estrogen receptors. Abnormal methylation of tumor suppressor genes and miRNAs, regulated by DNMTs, can promote tumorigenesis and drug resistance in breast cancer. BC cells undergo adaptive mutations, rearrange chromosomes, and repress tumor suppressor genes while inducing oncogene activities, leading to aggressive and heterogeneous cancer cells. Drug resistance in breast cancer is driven by various mechanisms, including the activation of signaling pathways, upregulation of drug efflux pumps, emergence of cancer stem cells, and genetic and epigenetic changes. The initiation and progression of breast cancer involve a multi-step process, with epithelial-mesenchymal transition playing a crucial role in facilitating metastasis.
What are the molecular mechanisms of breast cancer?4 answersBreast cancer is a complex pathology that involves the uncontrolled proliferation and growth of cells in the breast tissue. It is influenced by genetic and environmental risk factors. The development of breast cancer is associated with changes in signaling mechanisms mediated by estrogen and estrogen receptors. These signaling mechanisms have complex interaction patterns. Breast cancer cells undergo adaptive mutations, rearrange their chromosomes, and repress tumor suppressor genes while inducing oncogene activities, leading to the formation of heterogeneous cancer cells in the tumor environment. These genetic alterations result in aggressive breast cancer cells that can proliferate, migrate, invade other tissues, and form secondary tumors. Epigenetic alterations, such as dysregulation of the Enhancer of zeste homolog 2 (EZH2) molecule, also play a role in breast cancer development. Understanding the molecular mechanisms of breast cancer is crucial for developing effective therapeutic approaches.
What is the mechanism of breast cancer BM?5 answersBreast cancer is a complex pathology characterized by uncontrolled cell proliferation and growth. The molecular mechanisms underlying breast cancer initiation and progression are not fully understood, but epithelial-mesenchymal transition (EMT) plays a crucial role in promoting malignancy and metastasis. Abnormal methylation of tumor suppressor genes and miRNAs, as well as the overexpression of oncogenic miRNAs, have been implicated in breast cancer development and drug resistance. Estrogen and estrogen receptor-mediated signaling mechanisms also contribute to breast cancer pathogenesis. Additionally, deep learning models with attention mechanisms have shown promise in the early detection and classification of breast cancer based on microscopic images. Understanding these molecular mechanisms and developing potent therapeutic approaches is crucial for improving breast cancer treatment outcomes.